WHO ICTRP trial
Effect of Unani drugs in pelvic infection
CTRI/2018/03/012375 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2018/03/012375 |
|---|---|
| Public title | Effect of Unani drugs in pelvic infection |
| Scientific title | Efficacy of Tukhme Katan and Isapghol in Waram al-Rahim- A Randomized Standard Controlled Study |
| Primary sponsor | National Institue of Unani mediicne |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | India |
| Conditions | Health Condition 1: N74- Female pelvic inflammatory disorders in diseases classified elsewhere Health Condition 2: null- Pelvic Inflammatory Disease |
| Interventions | Intervention1: tukhme katan (3 gm) and tukhme isapghol (3 gm) with honey (5 ml): Orally placebo will be given for 14 days. Locally per vaginum powder of tukhme katan (3 gm) and tukhme isapghol (3 gm) with honey (5 ml) will be given for 14… |
| Registration date | Jun 3, 2018 |
| Target size | 66 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: